Does aspirin really reduce the risk of colon cancer?

The Lancet

Volumn 379, Issue 9826, 2012, Pages 1586-1587

  Jankowski, Janusz ^a,b,c   Barr, Hugh ^d   Moayyedi, Paul ^e  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^e MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

CANCER RISK; COLON CANCER; DISEASE SEVERITY; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; STROKE;

EID: 84860263902     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60672-2     Document Type: Letter

References (5)

1. Burn J, Gerdes AM, Macrae F, et al, on behalf of the CAPP2 Investigators. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011; 378: 2081-87.
2. Chen YL, Chang CL, Chen HC, et al. Major Adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy. Am J Cardiol 2011; 108: 1704-09.
3. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31-41.
4. Moayyedi P, Jankowski JA. Does long term aspirin prevent cancer? BMJ 2010; 341: c7326.
5. Jankowski J, Barr H, Wang K, Delaney B. Diagnosis and management of Barrett's oesophagus. BMJ 2010; 341: c4551.